St. Luke's Medical Center
14
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
PAIN OUT: Improvement in Postoperative PAIN OUTcome
Role: collaborator
Advanced SPinal Innovations With Robotics and Enabling Technology Registry
Role: collaborator
Alternate Day vs. Daily Iron Supplementation in Iron Depleted Women in the Philippines
Role: collaborator
Rapid Assessment of Trainee Endoscopy Skills (RATES) Study Two
Role: collaborator
Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy
Role: collaborator
Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)
Role: collaborator
Biological Therapy in Treating Women With Metastatic Breast Cancer
Role: lead
The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
Role: collaborator
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Role: lead
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Role: lead
Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
Role: lead
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Role: lead
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
Role: lead
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
Role: lead
All 14 trials loaded